Skip to main content
Study shows promising results for Provista's blood test for breast cancer

A study of 545 women ages 25 to 50 years showed that the use of Provista Diagnostics' Videssa Breast assay in breast cancer detection may lower biopsy use by up to 67%. The multiprotein biomarker blood test was found to have 87.5% sensitivity, 83.8% specificity, 99.1% negative predictive value and 25.2% positive predictive value.

Full Story: